Adverum Biotechnologies Inc (ADVM) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Thu April 8th, 2021

- 13:39
  Press ReleasesThe Sonic Fund II, L.P. Files Preliminary Proxy Statement Relating to the Election of Highly Qualified Independent Directors at the 2021 Annual Meeting of Adverum Biotechnologies, Inc.PR Newswire

Mon March 15th, 2021

- 13:46
  AnalysisKodiak Sciences Offers Multiple Shots On Goal For Eye Treatments, Multiple Catalysts Expected In 2022Seeking Alpha

Wed March 3rd, 2021

- 20:52
  EarningsAnalysisAdverum Biotechnologies, Inc. 2020 Q4 - Results - Earnings Call PresentationSeeking Alpha

Tue March 2nd, 2021

- 12:31
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisAdverum Biotechnologies, Inc. (ADVM) Q4 2020 Earnings Call TranscriptThe Motley Fool
- 04:24
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisAdverum Biotechnologies, Inc's (ADVM) CEO Laurent Fischer on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Mon March 1st, 2021

- 22:25
  AnalysisAdverum Biotechnologies (ADVM) Reports Q4 Loss, Misses Revenue EstimatesZacks + 2 more

Mon January 25th, 2021

- 11:46
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisInsider Weekends: Insiders Of Driven Brands Driven To Buy MoreSeeking Alpha

Mon January 11th, 2021

- 17:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  RatingAnalysisAll You Need to Know About Adverum Biotechnologies (ADVM) Rating Upgrade to BuyZacks
- 00:16
  AnalysisAdverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated MarketSeeking Alpha

Fri January 8th, 2021

- 13:49
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisImplied Volatility Surging for Adverum Biotechnologies (ADVM) Stock OptionsZacks

Mon December 21st, 2020

- 17:47
  AnalysisPharming Group Lines Up U.S. Offering PlanSeeking Alpha

Thu November 5th, 2020

- 23:35
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAdverum Biotechnologies (ADVM) Reports Q3 Loss, Misses Revenue EstimatesZacks

Fri October 9th, 2020

- 12:56
  AnalysisIs the Options Market Predicting a Spike in Adverum Biotechnologies (ADVM) Stock?Zacks

Tue October 6th, 2020

- 17:48
  AnalysisGene Therapy Stocks - A Buying OpportunitySeeking Alpha

Tue September 29th, 2020

- 17:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisGuideAssessing AdverumSeeking Alpha

Mon August 17th, 2020

- 12:51
  AnalysisAdverum (ADVM) Surges: Stock Moves 6.2% HigherZacks

Wed August 12th, 2020

- 16:50
  AnalysisEquillium Jumps On Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Tue August 11th, 2020

Mon August 10th, 2020

- 21:35
  AnalysisAdverum Biotechnologies (ADVM) Reports Q2 Loss, Lags Revenue EstimatesZacks + 17 more

Fri June 26th, 2020

- 21:52
  RatingAdverum Biotechnologies downgraded to umderperform from market perform at Raymond JamesMarketWatch

Fri June 12th, 2020

- 20:40
  AnalysisAdverum Biotechnologies (ADVM) Investor Presentation - SlideshowSeeking Alpha

Fri May 29th, 2020

Thu May 28th, 2020

- 23:06
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisAdverum Biotechnologies, Inc. 2020 Q1 - Results - Earnings Call PresentationSeeking Alpha
- 21:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAdverum Biotechnologies (ADVM) Reports Q1 Loss, Lags Revenue EstimatesZacks + 2 more

Mon May 25th, 2020

- 15:30
  AnalysisHas Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?Zacks

SPY$395.63-3.2%

QQQ$315.85-5.7%

DOW$64.141.5%

CCF$115.74-1.5%

NVDA$513.35-10%

SPY$395.63-3.2%

QQQ$315.85-5.7%

DOW$64.141.5%

CCF$115.74-1.5%

NVDA$513.35-10%

About Developer Contact